Skip to main content
Log in

Abatacept in rheumatoid arthritis: risk of cancer?

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Montastruc F, et al. Abatacept initiation in rheumatoid arthritis and the risk of cancer: a population-based comparative cohort study. Rheumatology : 7 Dec 2018. Available from: URL: http://doi.org/10.1093/rheumatology/key352

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abatacept in rheumatoid arthritis: risk of cancer?. Reactions Weekly 1735, 5 (2019). https://doi.org/10.1007/s40278-019-56621-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-56621-1

Navigation